Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared. If approved as a test, doctors might detect cancers sooner and treat them ...

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...